Knoll Capital Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History
Knoll Capital Management, LLC
- $203 Million
- Q3 2024
A detailed history of Knoll Capital Management, LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 710,422 shares of BHVN stock, worth $33.3 Million. This represents 17.51% of its overall portfolio holdings.
Number of Shares
710,422
Previous 710,422
-0.0%
Holding current value
$33.3 Million
Previous $24.7 Million
43.97%
% of portfolio
17.51%
Previous 16.66%
Shares
9 transactions
Others Institutions Holding BHVN
# of Institutions
11Shares Held
792KCall Options Held
0Put Options Held
0-
Eaton Vance Management Boston, MA35.9KShares$1.68 Million0.01% of portfolio
-
S. Muoio & Co. LLC New York, NY19KShares$888,8333.79% of portfolio
-
Agf Investments LLC Boston, MA11.6KShares$541,3540.16% of portfolio
-
Birchview Capital, LP Burlington, VT7.37KShares$344,9020.34% of portfolio
-
Brevan Howard Capital Management LP St. Helier, Y96.52KShares$305,4720.0% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $3.36B
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...